Lawler Jack相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Correction: SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2

更正：SCFβ-TRCP 通过促进 VEGF 受体 2 的泛素化和破坏来抑制血管生成和甲状腺癌细胞迁移。

期刊:Journal of Experimental Medicine

影响因子:10.6

doi:10.1084/jem.2011244608082025c

Shaik, Shavali; Nucera, Carmelo; Inuzuka, Hiroyuki; Gao, Daming; Garnaas, Maija; Frechette, Gregory; Harris, Lauren; Wan, Lixin; Fukushima, Hidefumi; Husain, Amjad; Nose, Vania; Fadda, Guido; Sadow, Peter M; Goessling, Wolfram; North, Trista; Lawler, Jack; Wei, Wenyi

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas

TSP-1的抗血管生成变体靶向胶质母细胞瘤中的肿瘤细胞

期刊:Molecular Therapy

影响因子:12

doi:10.1016/j.ymthe.2024.04.022

Choi, Sung Hugh; Tamura, Kaoru; Khajuria, Rajiv Kumar; Bhere, Deepak; Nesterenko, Irina; Lawler, Jack; Shah, Khalid

细胞生物学

发表日期：2024

文献求助收藏

Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake

通过肿瘤血管正常化来减少缺氧、增强灌注并优化治疗吸收

影响因子:4.4

doi:10.3390/cancers13174444

Matuszewska, Kathy; Pereira, Madison; Petrik, Duncan; Lawler, Jack; Petrik, Jim

发表日期：2021

文献求助收藏

Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1

内皮细胞行为由血小板反应蛋白-1诱导的受体聚集决定

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2021.664696

Morandi, Verônica; Petrik, Jim; Lawler, Jack

细胞生物学

发表日期：2021

文献求助收藏

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment

更正：血小板反应蛋白-1沉默下调BRAF(V600E)突变型人间变性甲状腺癌细胞中整合素的表达水平：对宿主组织适应和肿瘤微环境稳态的新见解

期刊:Frontiers in Endocrinology

影响因子:4.6

doi:10.3389/fendo.2020.596223

Duquette, Mark; Sadow, Peter M; Lawler, Jack; Nucera, Carmelo

细胞生物学

肿瘤微环境

免疫/内分泌

发表日期：2020

文献求助收藏

Readmission to hospital following laparoscopic cholecystectomy: a meta-analysis

腹腔镜胆囊切除术后再次入院：一项荟萃分析

期刊:Anaesthesiology Intensive Therapy

影响因子:1.7

doi:10.5114/ait.2020.92967

McIntyre, Caroline; Johnston, Alison; Foley, Deirdre; Lawler, Jack; Bucholc, Magda; Flanagan, Louise; Sugrue, Michael

发表日期：2020

文献求助收藏

Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFÎ²1 Axis.

周细胞通过 TSP-1/TGFβ1 轴诱导甲状腺癌对维莫非尼和索拉非尼治疗产生耐药性

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-18-0693

Prete Alessandro, Lo Agnes S, Sadow Peter M, Bhasin Swati S, Antonello Zeus A, Vodopivec Danica M, Ullas Soumya, Sims Jennifer N, Clohessy John, Dvorak Ann M, Sciuto Tracey, Bhasin Manoj, Murphy-Ullrich Joanne E, Lawler Jack, Karumanchi S Ananth, Nucera Carmelo

细胞生物学

发表日期：2018

文献求助收藏

Integration of pro- and anti-angiogenic signals by endothelial cells

内皮细胞对促血管生成和抗血管生成信号的整合

期刊:Journal of Cell Communication and Signaling

影响因子:3.9

doi:10.1007/s12079-017-0433-3

Kazerounian, Shideh; Lawler, Jack

细胞生物学

发表日期：2018

文献求助收藏

Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer

在晚期上皮性卵巢癌的临床前模型中，血小板反应蛋白-1 I型重复序列（3TSR）联合化疗可诱导肿瘤消退并显著提高生存率。

期刊:FASEB Journal

影响因子:4.2

doi:10.1096/fj.14-261636

Russell, Samantha; Duquette, Mark; Liu, Joyce; Drapkin, Ronny; Lawler, Jack; Petrik, Jim

发表日期：2015

文献求助收藏

Thrombospondin-1-Based Antiangiogenic Therapy

基于血小板反应蛋白-1的抗血管生成疗法

期刊:Journal of Ocular Pharmacology and Therapeutics

影响因子:2.1

doi:10.1089/jop.2015.0018

Sims, Jennifer N; Lawler, Jack

发表日期：2015

文献求助收藏